Carrier Detection

Carrier testing using molecular genetic testing of the CYP21A2 gene is available to at-risk relatives when one or both disease-causing mutations have been identified in the proband. Although carriers may have slightly elevated serum concentration of 17-OHP when stimulated with ACTH compared to noncarriers, there is overlap between heterozygotes and noncarriers. Thus, molecular genetic testing is the preferred method of carrier testing.